Fampyra on Morning Ireland
Earlier today RTÉ's Morning Ireland featured a segment on the impact of losing access to Fampyra on two people with MS.
Earlier today RTÉ's Morning Ireland featured a segment on the impact of losing access to Fampyra on two people with MS.
'MS & Me Blog marks one year by looking back and looking forward'
The following is a statement from Biogen Idec regarding the avilability of Fampyra, issued on Tuesday, 11th November 2014.
© 2010 - 2024 Multiple Sclerosis Society of Ireland